We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+6.45%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$30.8B
AUM Growth
+$741M
(+2.5%)
Cap. Flow
-$14.8B
Cap. Flow
% of AUM
-47.97%
Top 10 Holdings %
Top 10 Hldgs %
8.31%
Holding
851
New
152
Increased
227
Reduced
305
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$92.3M |
| 2 |
Clorox
CLX
|
+$90.2M |
| 3 |
Universal Health Services
UHS
|
+$86.5M |
| 4 |
American International
AIG
|
+$81.4M |
| 5 |
Corteva
CTVA
|
+$74.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
|
+$13.2B |
| 2 |
Bank of America
BAC
|
+$164M |
| 3 |
DuPont de Nemours
DD
|
+$120M |
| 4 |
Intuitive Surgical
ISRG
|
+$102M |
| 5 |
Johnson & Johnson
JNJ
|
+$93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 14.54% |
| 3 | Financials | 14.22% |
| 4 | Industrials | 11.55% |
| 5 | Consumer Discretionary | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
VanEck Junior Gold Miners ETF
GDXJ
$6.95B
| $12.9M | 0.04% |
369,998
+550
| +0.1% | +$16.8K |
|
|
RARX
477
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $12.8M | 0.04% |
424,862
+102,077
| +32% | +$2.34M |
|
478
Clear Channel Outdoor Holdings
CCO
$1.22B
| $12.6M | 0.04% |
+2,679,125
| New | +$13.7M |
|
479
Analog Devices
ADI
$175B
| $12.6M | 0.04% |
111,978
+9,289
| +9% | +$1.01M |
|
480
MacroGenics
MGNX
$236M
| $12.6M | 0.04% |
741,191
+97,321
| +15% | +$1.67M |
|
481
Trupanion
TRUP
$1.13B
| $12.5M | 0.04% |
347,301
+101,163
| +41% | +$3.32M |
|
|
VAPO
482
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $12.5M | 0.04% |
68,105
+21,732
| +47% | +$3.22M |
|
483
Evercore
EVR
$11.8B
| $12.5M | 0.04% |
141,238
-452
| -0.3% | -$40.2K |
|
484
Adaptive Biotechnologies
ADPT
$3.54B
| $12.4M | 0.04% |
+255,906
| New | +$11.3M |
|
|
TPTX
485
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $12.3M | 0.04% |
+302,746
| New | +$10.8M |
|
486
Euronet Worldwide
EEFT
$3.17B
| $12.3M | 0.04% |
73,133
-818
| -1% | -$125K |
|
487
Yext
YEXT
$578M
| $11.8M | 0.04% |
+585,190
| New | +$12M |
|
488
Williams-Sonoma
WSM
$27.4B
| $11.7M | 0.04% |
+360,868
| New | +$10.4M |
|
489
Alarm.com
ALRM
$2.77B
| $11.6M | 0.04% |
216,682
+22,923
| +12% | +$1.41M |
|
490
Selective Insurance
SIGI
$5.72B
| $11.6M | 0.04% |
+154,453
| New | +$11M |
|
491
Hamilton Lane
HLNE
$3.89B
| $11.5M | 0.04% |
+201,326
| New | +$10.1M |
|
|
SWP
492
DELISTED
Stanley Black & Decker, Inc. Corporate Units
SWP
| $11.3M | 0.04% |
111,961
+75,299
| +205% | +$7.56M |
|
493
GoDaddy
GDDY
$14B
| $11.1M | 0.04% |
157,820
+9,130
| +6% | +$689K |
|
494
OrthoPediatrics
KIDS
$515M
| $11M | 0.04% |
283,249
+114,286
| +68% | +$4.61M |
|
495
CrowdStrike
CRWD
$184B
| $10.9M | 0.04% |
+639,724
| New | +$10.9M |
|
496
Boston Beer
SAM
$1.92B
| $10.9M | 0.04% |
+28,907
| New | +$9.15M |
|
497
Victory Capital Holdings
VCTR
$6.12B
| $10.8M | 0.04% |
629,946
+198,654
| +46% | +$3.28M |
|
498
Alector
ALEC
$170M
| $10.8M | 0.04% |
568,864
+74,738
| +15% | +$1.52M |
|
|
TCF
499
DELISTED
TCF Financial Corporation
TCF
| $10.6M | 0.03% |
+507,704
| New | +$10.6M |
|
500
Badger Meter
BMI
$3.82B
| $10.5M | 0.03% |
175,777
+23,060
| +15% | +$1.28M |
|
Similar funds
Lord, Abbett & Co's Q2 2019 Portfolio in Review
As of Q2 2019, Lord, Abbett & Co held 851 positions worth $30.8B, up 2.5% from $30B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
Lord, Abbett & Co withdrew a net $14.8B in Q2 2019, closing 99 positions and reducing 305 holdings. Its most notable exit was DuPont de Nemours, an estimated $120M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lord, Abbett & Co opened a new position in Dow Inc worth $86.2M.
- Lord, Abbett & Co's largest Q2 2019 buy was Dow Inc: 1,747,600 shares worth $86.2M.
- Lord, Abbett & Co added most to Clorox in Q2 2019, an estimated $90.2M increase.
- Lord, Abbett & Co's biggest Q2 2019 reduction was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A, cutting an estimated $13.2B.
- Lord, Abbett & Co fully exited DuPont de Nemours in Q2 2019, selling an estimated $120M.
- Lord, Abbett & Co's ten largest holdings make up 8.3% of its $30.8B portfolio in Q2 2019.
- Lord, Abbett & Co opened 152 new positions and closed 99 in Q2 2019.
- Lord, Abbett & Co's portfolio value rose 2.5% quarter-over-quarter to $30.8B.
Based on Lord, Abbett & Co's 13F filing for Q2 2019, filed 14 Aug 2019.